Rethinking spondyloarthritis: beyond lumping and splitting
Author:
- 13 May 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 37 (4) , 207-214
Abstract
Purpose of review: The classification of spondyloarthritis (SpA) has long been debated, with ongoing discussions about whether to “lump” various subtypes together or “split” them into smaller distinct disease categories. This review explores the evolution of the SpA concept and discusses novel approaches that move beyond traditional models of SpA classification. Recent findings: Since its introduction in the 1970s, the SpA concept has undergone substantial modifications, incorporating advances in genetics, imaging, and clinical research. The recognition of axial and peripheral SpA as distinct yet overlapping entities has reshaped classification and drug approval processes. Data-driven methodologies have provided new insights into disease heterogeneity. Recent research highlights the limitations of traditional classification systems, emphasizing the need for unbiased approaches that integrate clinical and molecular features. Summary: Current historically derived classification paradigms for SpA are largely based on clinical phenotype and fail to capture the full spectrum of disease heterogeneity. Defining SpA subsets by incorporating genetic and immunological characteristics may improve diagnostic precision and improve outcomes. Future research should focus on refining classification frameworks across the entire clinical spectrum of SpA to improve patient stratification, guide treatment decisions, and address existing gaps in SpA care.Keywords
This publication has 66 references indexed in Scilit:
- Emerging Concepts in Precision Medicine in Axial SpondyloarthritisCurrent Rheumatology Reports, 2023
- Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?Clinical Rheumatology, 2022
- Axial Psoriatic ArthritisCurrent Rheumatology Reports, 2021
- Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial SpondyloarthritisArthritis & Rheumatology, 2018
- Two Phenotypes Are Identified by Cluster Analysis in Early Inflammatory Back Pain Suggestive of Spondyloarthritis: Results From the DESIR CohortArthritis & Rheumatology, 2016
- Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral SpondyloarthritisArthritis & Rheumatology, 2015
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006
- Subsets in Psoriatic Arthritis formed by Cluster AnalysisClinical Rheumatology, 2001
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984